c-Jun N-terminal kinases
mitogen-activated protein kinase 8 | |
---|---|
Identifiers | |
Symbol | MAPK8 |
Alt. symbols | JNK1, PRKM8 |
Entrez | 5599 |
HUGO | 6881 |
OMIM | 601158 |
RefSeq | NM_002750 |
UniProt | P45983 |
Other data | |
Locus | Chr. 10 q11.2 |
mitogen-activated protein kinase 9 | |
---|---|
Identifiers | |
Symbol | MAPK9 |
Alt. symbols | JNK2, PRKM9 |
Entrez | 5601 |
HUGO | 6886 |
OMIM | 602896 |
RefSeq | NM_002752 |
UniProt | P45984 |
Other data | |
Locus | Chr. 5 q35 |
mitogen-activated protein kinase 10 | |
---|---|
Identifiers | |
Symbol | MAPK10 |
Alt. symbols | JNK3, PRKM10 |
Entrez | 5602 |
HUGO | 6872 |
OMIM | 602897 |
RefSeq | NM_002753 |
UniProt | P53779 |
c-Jun N-terminal kinases (JNKs), were originally identified as kinases that bind and phosphorylate c-Jun on Ser-63 and Ser-73 within its transcriptional activation domain. They belong to the mitogen-activated protein kinase family, and are responsive to stress stimuli, such as cytokines, ultraviolet irradiation, heat shock, and osmotic shock. They also play a role in T cell differentiation and the cellular apoptosis pathway. Activation occurs through a dual phosphorylation of threonine (Thr) and tyrosine (Tyr) residues within a Thr-Pro-Tyr motif located in kinase subdomain VIII. Activation is carried out by two MAP kinases, MKK4 and MKK7 and JNK can be inactivated by Ser/Thr and Tyr protein phosphatases.[1] It has been suggested that this signaling pathway contributes to inflammatory responses in mammals and insects.
Isoforms
The c-Jun N-terminal kinases consist of ten isoforms derived from three genes: JNK1 (four isoforms), JNK2 (four isoforms) and JNK3 (two isoforms).[2] Each gene is expressed as either 46 kDa or 55 kDa protein kinases, depending upon how the 3' coding region of the corresponding mRNA is processed. There have been no functional differences documented between the 46 kDa and the 55 kDa isoform, however, a second form of alternative splicing occurs within transcripts of JNK1 and JNK2, yielding JNK1-α, JNK2-α and JNK1-β and JNK2-β. Differences in interactions with protein substrates arise because of the mutually exclusive utilization of two exons within the kinase domain.[1]
c-Jun N-terminal kinase isoforms have the following tissue distribution:
- JNK1 and JNK2 are found in all cells and tissues.[3]
- JNK3 is found mainly in the brain, but is also found in the heart and the testes.[3]
Function
Inflammatory signals, changes in levels of reactive oxygen species, ultraviolet radiation, protein synthesis inhibitors, and a variety of stress stimuli can activate JNK. One way this activation may occur is through disruption of the conformation of sensitive protein phosphatase enzymes; specific phosphatases normally inhibit the activity of JNK itself and the activity of proteins linked to JNK activation.[4]
JNKs can associate with scaffold proteins JNK interacting proteins as well as their upstream kinases JNKK1 and JNKK2 following their activation.
JNK, by phosphorylation, modifies the activity of numerous proteins that reside at the mitochondria or act in the nucleus. Downstream molecules that are activated by JNK include c-Jun, ATF2, ELK1, SMAD4, p53 and HSF1. The downstream molecules that are inhibited by JNK activation include NFAT4, NFATC1 and STAT3. By activating and inhibiting other small molecules in this way, JNK activity regulates several important cellular functions including cell growth, differentiation, survival and apoptosis.
JNK1 is involved in apoptosis, neurodegeneration, cell differentiation and proliferation, inflammatory conditions and cytokine production mediated by AP-1 (activation protein 1) such as RANTES, IL-8 and GM-CSF.[5]
Recently, JNK1 has been found to regulate Jun protein turnover by phosphorylation and activation of the ubiquitin ligase Itch.
Roles of JNK in DNA repair
The packaging of eukaryotic DNA into chromatin presents a barrier to all DNA-based processes that require recruitment of enzymes to their sites of action. To allow repair of double-strand breaks in DNA, the chromatin must be remodeled.[6] Chromatin relaxation occurs rapidly at the site of a DNA damage.[7] In one of the earliest steps, JNK phosphorylates SIRT6 on serine 10 in response to double-strand breaks (DSBs) or other DNA damage, and this step is required for efficient repair of DSBs.[8] Phosphorylation of SIRT6 on S10 facilitates the mobilization of SIRT6 to DNA damage sites, where SIRT6 then recruits and mono-phosphorylates poly (ADP-ribose) polymerase 1 (PARP1) at DNA break sites.[8] Half maximum accumulation of PARP1 occurs within 1.6 seconds after the damage occurs.[9] The chromatin remodeler Alc1 quickly attaches to the product of PARP1 action, a poly-ADP ribose chain,[7] allowing half of the maximum chromatin relaxation, presumably due to action of Alc1, by 10 seconds.[7] This allows recruitment of the DNA repair enzyme MRE11, to initiate DNA repair, within 13 seconds.[9]
Removal of UV-induced DNA photoproducts, during transcription coupled nucleotide excision repair (TC-NER), depends on JNK phosphorylation of DGCR8 on serine 153.[10] While DGCR8 is usually known to function in microRNA biogenesis, the microRNA-generating activity of DGCR8 is not required for DGCR8-dependent removal of UV-induced photoproducts.[10] Nucleotide excision repair is also needed for repair of oxidative DNA damage due to hydrogen peroxide (H2O2), and DGCR8 depleted cells are sensitive to H2O2.[10]
JNK in aging
In Drosophila, flies with mutations that augment JNK signaling accumulate less oxidative damage and live dramatically longer than wild-type flies.[11][12]
In the tiny roundworm Caenorhabditis elegans, loss-of-function mutants of JNK-1 have a decreased life span, while amplified expression of wild-type JNK-1 extends life span by 40%.[13] Worms with overexpressed JNK-1 also have significantly increased resistance to oxidative stress and other stresses.[13]
References
- 1 2 Ip YT, Davis RJ (April 1998). "Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development". Curr. Opin. Cell Biol. 10 (2): 205–19. PMID 9561845. doi:10.1016/S0955-0674(98)80143-9.
- ↑ Waetzig V, Herdegen T (2005). "Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage". Br. J. Pharmacol. 26 (9): 455–61. PMID 16054242. doi:10.1016/j.tips.2005.07.006.
- 1 2 Bode AM, Dong Z (August 2007). "The Functional Contrariety of JNK". Mol. Carcinog. 46 (8): 591–8. PMC 2832829 . PMID 17538955. doi:10.1002/mc.20348.
The protein products of jnk1 and jnk2 are believed to be expressed in every cell and tissue type, whereas the JNK3 protein is found primarily in brain and to a lesser extent in heart and testis
- ↑ Vlahopoulos S, Zoumpourlis VC (August 2004). "JNK: a key modulator of intracellular signaling". Biochemistry Mosc. 69 (8): 844–54. PMID 15377263. doi:10.1023/B:BIRY.0000040215.02460.45.
- ↑ Oltmanns U, Issa R, Sukkar MB, John M, Chung KF (July 2003). "Role of c-jun N-terminal kinase in the induced release of GM-CSF, RANTES and IL-8 from human airway smooth muscle cells". Br. J. Pharmacol. 139 (6): 1228–34. PMC 1573939 . PMID 12871843. doi:10.1038/sj.bjp.0705345.
- ↑ Liu B, Yip RK, Zhou Z (2012). "Chromatin remodeling, DNA damage repair and aging". Curr. Genomics. 13 (7): 533–47. PMC 3468886 . PMID 23633913. doi:10.2174/138920212803251373.
- 1 2 3 Sellou H, Lebeaupin T, Chapuis C, Smith R, Hegele A, Singh HR, Kozlowski M, Bultmann S, Ladurner AG, Timinszky G, Huet S (2016). "The poly(ADP-ribose)-dependent chromatin remodeler Alc1 induces local chromatin relaxation upon DNA damage". Mol. Biol. Cell. 27 (24): 3791–3799. PMC 5170603 . PMID 27733626. doi:10.1091/mbc.E16-05-0269.
- 1 2 Van Meter M, Simon M, Tombline G, May A, Morello TD, Hubbard BP, Bredbenner K, Park R, Sinclair DA, Bohr VA, Gorbunova V, Seluanov A (2016). "JNK Phosphorylates SIRT6 to Stimulate DNA Double-Strand Break Repair in Response to Oxidative Stress by Recruiting PARP1 to DNA Breaks". Cell Rep. 16 (10): 2641–50. PMID 27568560. doi:10.1016/j.celrep.2016.08.006.
- 1 2 Haince JF, McDonald D, Rodrigue A, Déry U, Masson JY, Hendzel MJ, Poirier GG (2008). "PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites". J. Biol. Chem. 283 (2): 1197–208. PMID 18025084. doi:10.1074/jbc.M706734200.
- 1 2 3 Calses PC, Dhillon KK, Tucker N, Chi Y, Huang JW, Kawasumi M, Nghiem P, Wang Y, Clurman BE, Jacquemont C, Gafken PR, Sugasawa K, Saijo M, Taniguchi T (2017). "DGCR8 Mediates Repair of UV-Induced DNA Damage Independently of RNA Processing". Cell Rep. 19 (1): 162–174. PMID 28380355. doi:10.1016/j.celrep.2017.03.021.
- ↑ Wang MC, Bohmann D, Jasper H (2003). "JNK signaling confers tolerance to oxidative stress and extends lifespan in Drosophila". Dev. Cell. 5 (5): 811–6. PMID 14602080.
- ↑ Wang MC, Bohmann D, Jasper H (2005). "JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling". Cell. 121 (1): 115–25. PMID 15820683. doi:10.1016/j.cell.2005.02.030.
- 1 2 Oh SW, Mukhopadhyay A, Svrzikapa N, Jiang F, Davis RJ, Tissenbaum HA (2005). "JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16". Proc. Natl. Acad. Sci. U.S.A. 102 (12): 4494–9. PMC 555525 . PMID 15767565. doi:10.1073/pnas.0500749102.
External links
- JNK Mitogen-Activated Protein Kinases at the US National Library of Medicine Medical Subject Headings (MeSH)
- Getting a Handle on Cellular JNK (from Beaker Blog)
- MAP Kinase Resource